PubCoCEO™

MicroCap Toxic Debt – A Guide For MicroCap CEOs

Toxic debt is a very important topic for microcap professionals but it is seemingly taboo to discuss microcap toxic debt in public… on the internet. There are few reliable sources of information on microcap toxic debt online. We have compiled some of our best content on the topic here and will continue to add links to this post (below) as we add more to our website.

Toxic microcap funding usually comes in the form of small ‘floor-less’ convertible notes but there are also other forms of toxic financing. It’s often difficult for first time microcap CEOs and CFOs to spot toxic financing but for experienced professionals toxic financing can be spotted from a mile away.

If you are a microcap professional that would like to share your insights on microcap toxic debt in the form of a guest post, please Contact Us.

Things to consider before taking ‘toxic funding’: 

TOXIC DEBT: WHAT IS IT AND HOW CAN MICRO-CAP CEO’S AVOID IT? [GUEST POST]

CEO’S OF MICROCAP PUBCO’S: TO CONFESS OR NOT TO CONFESS (JUDGMENTS THAT IS) [GUEST POST]

CRITICAL QUESTIONS MICROCAP ISSUERS SHOULD ASK REGARDING IRREVOCABLE TRANSFER AGENT INSTRUCTION LETTERS

FINANCING TRENDS FOR 2017 FROM A LEGAL PERSPECTIVE — PLANET MICROCAP SHOWCASE PANEL

Information for dealing with existing toxic debt: 

TIPS FOR MICROCAP CEOS HANDLING ‘TOXIC’ DEBT [GUEST POST]

MARKET MAKERS UNDERSTAND MICROCAP TOXIC DEBT

SEC GOES AFTER MICROCAP FOR FAILING TO DISCLOSE CONVERTIBLE NOTE FINANCING

The future of microcap toxic debt: 

OTC MARKETS WORKING ON POTENTIAL SOLUTIONS TO STOCK PROMOTIONS & TOXIC FINANCING

COULD THE END OF TOXIC CONVERTIBLE NOTES WITH HUGE DISCOUNTS BE IN SIGHT? [GUEST POST]